10x Genomics Stock Investor Sentiment

TXG Stock  USD 10.34  0.46  4.66%   
Roughly 56% of all 10X Genomics' stockholders are looking to take a long position. The analysis of overall sentiment of trading 10X Genomics stock suggests that some investors are interested at this time. The current market sentiment, together with 10X Genomics' historical and current headlines, can help investors time the market. In addition, many technical investors use 10X Genomics stock news signals to limit their universe of possible portfolio assets.
  
over two months ago at seekingalpha.com         
Disposition of 12000 shares by Serge Saxonov of 10X Genomics at 1.2 subject to Rule 16b-3
seekingalpha News
over two months ago at thelincolnianonline.com         
MT Bank Corp Takes Position in 10x Genomics, Inc.
news
over two months ago at investing.com         
10X Genomics SWOT analysis genomics firm navigates challenges, eyes recovery
Investing News at Macroaxis
over three months ago at news.google.com         
XTX Topco Ltd Purchases 31,844 Shares of 10x Genomics, Inc. - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
46,029 Shares in 10x Genomics, Inc. Purchased by Weiss Asset Management LP - MarketBeat
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Disposition of 441 shares by Justin McAnear of 10X Genomics at 55.0641 subject to Rule 16b-3
Macroaxis News
over three months ago at thelincolnianonline.com         
Point72 Asset Management L.P. Makes New 27.78 Million Investment in 10x Genomics, Inc.
news
over three months ago at gurufocus.com         
10x Genomics Inc Stock Price Down 3.81 percent on Dec 5
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
10x Genomics Inc Shares Up 2.74 percent on Dec 2
Gurufocus Stories at Macroaxis
over three months ago at thelincolnianonline.com         
PDT Partners LLC Reduces Stock Position in 10x Genomics, Inc.
news
over three months ago at gurufocus.com         
10x Genomics Inc Shares Up 3.13 percent on Nov 28
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
10x Genomics Inc Trading Down 3.99 percent on Nov 26
Gurufocus Stories at Macroaxis
over three months ago at investing.com         
10x genomics chief scientific officer sells 79,485 in stock
Investing News at Macroaxis
over three months ago at investing.com         
10x genomics CEO Serge Saxonov sells 91,612 in stock
Investing News at Macroaxis
over three months ago at gurufocus.com         
Disposition of 5807 shares by Benjamin Hindson of 10X Genomics at 13.6878 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about 10X Genomics that are available to investors today. That information is available publicly through 10X media outlets and privately through word of mouth or via 10X internal channels. However, regardless of the origin, that massive amount of 10X data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 10X Genomics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 10X Genomics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 10X Genomics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 10X Genomics alpha.

10X Genomics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for 10X Stock analysis

When running 10X Genomics' price analysis, check to measure 10X Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X Genomics is operating at the current time. Most of 10X Genomics' value examination focuses on studying past and present price action to predict the probability of 10X Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X Genomics' price. Additionally, you may evaluate how the addition of 10X Genomics to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes